『Power to the Patients』のカバーアート

Power to the Patients

Power to the Patients

著者： Brandon Li
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com315762 生物科学 科学
エピソード
  • 70% Remission for Postpartum Depression? The Psychedelic Breakthrough

    70% Remission for Postpartum Depression? The Psychedelic Breakthrough
    2026/04/30
    Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the success of the RECONNECT study and the path to FDA breakthrough designation.
    続きを読む 一部表示
    36 分
  • Why Psychiatry Is Finally Breaking Free From Dopamine

    Why Psychiatry Is Finally Breaking Free From Dopamine
    2026/04/15
    In this episode of Power to the Patients, host Brandon Li sits down with Ken Kramer, PhD, Vice President and Head of Neuropsychiatry Medical Affairs at Bristol Myers Squibb, to explore why psychiatry has lagged behind other therapeutic areas and what’s finally changing. Kramer explains how decades of reliance on dopamine-based antipsychotics shaped treatment, and why new mechanisms like muscarinic agonism are opening the door to safer, more effective options for patients with schizophrenia.
    続きを読む 一部表示
    29 分
  • Precision Medicine Got Kidney Disease Wrong—Until Now

    Precision Medicine Got Kidney Disease Wrong—Until Now
    2026/04/01
    Explore how variant functionalization is driving the future of mechanism-driven medicines as host Brandon interviews Jason Coloma, CEO of Maze Therapeutics, on Power to the Patients. Jason explains why most gene-disease associations fail to become therapies, how APOL1-mediated kidney disease reveals the power of precision nephrology, and what it actually takes to build an integrated genetics-to-drug-discovery platform.
    続きを読む 一部表示
    42 分
adbl_web_anon_alc_button_suppression_c
まだレビューはありません